Human prothrombin complex (Guangdong Wellen)

人凝血酶原复合物（广东卫伦）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman prothrombin complex (Guangdong Wellen)
Drug Alias Name凝血酶原复合体浓缩物 - 广东卫伦
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIIProthrombinCoagulation factor IX +[4] 
Therapy Area/IndicationsHemorrhageHemophilia B
Global Approved IndicationsHemorrhage
Approved Indications in ChinaHemorrhage
Original Approved Country/TerritoryMainland China
Original Approved Date2020/10/21
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGuangdong Wellen Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangdong Wellen Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhage
Inactive IndicationsHemophilia B

Other Information

ATC CodeB02BD01
Related LinksN/A